|
US2013172324A1
|
|
Method for treating cardiovascular diseases using rho kinase inhibitor compounds
|
|
US2013158014A1
|
|
Method for treating diseases associated with alterations in cellular integrity using rho kinase inhibitor compounds
|
|
WO2012092378A1
|
|
Method for treating blepharitis
|
|
WO2012092375A1
|
|
Method for treating dry eye
|
|
MX2013004030A
|
|
Method for treating cystic fibrosis with inhaled denufosol.
|
|
WO2012015760A1
|
|
Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms
|
|
AU2011279909A1
|
|
Bifunctional rho kinase inhibitor compounds, composition and use
|
|
CA2803407A1
|
|
Medicine dispenser
|
|
EP2512239A1
|
|
Bridged bicyclic rho kinase inhibitor compounds, composition and use
|
|
EP2393355A1
|
|
Method of treating dry eye disease with azithromycin
|
|
WO2010080540A1
|
|
Method for treating inflammatory conditions
|
|
WO2010065782A1
|
|
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
|
WO2010048341A1
|
|
Method for treating cystic fibrosis
|
|
AU2009268372A1
|
|
Method of treating blepharitis
|
|
EP2317849A1
|
|
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
|
EP2299820A1
|
|
Ophthalmic formulation of rho kinase inhibitor compound
|
|
MX2010013952A
|
|
Process for the preparation of rho-kinase inhibitor compounds.
|
|
US2009076256A1
|
|
Degradation-resistant mononucleoside phosphate compounds
|
|
WO2008098122A2
|
|
Method for treating allergic rhinitis without adverse effects
|
|
AU2007333715A1
|
|
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
